COMP <GO>
CL vs TSLA // REVENUE GROWTH (YOY)
Colgate-Palmolive Company (NYSE) VS. Tesla, Inc. (NASDAQ) • 15-METRIC TALLY: CL 9
— TSLA 4
▲ REVENUE GROWTH (YOY) LEADER: TSLA
LAST: $95.29 (+2.29%) • MKT CAP: $74.26B
revenue-growth
1.40%
LAST: $399.81 (-0.87%) • MKT CAP: $1.58T
revenue-growth
8.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CL VS. TSLA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CL | TSLA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 60.10% | 19.29% | +40.81 | CL | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 44.00% | 3.39% | +40.61 | CL | /roic <GO> |
| EV/EBITDA & P/E Valuation | 19.5x | 199.0x | -179.54 | CL | /valuation <GO> |
| Free Cash Flow Yield | 4.42% | 0.21% | +4.21 | CL | /fcf-yield <GO> |
| Operating Margin | 16.20% | 3.35% | +12.85 | CL | /operating-margins <GO> |
| Net Profit Margin | 10.50% | 3.11% | +7.39 | CL | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 1.40% | 8.30% | -6.90 | TSLA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.90 | 15.35 | -8.45 | TSLA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 5/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.30% | 8.72% | -1.42 | CL | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 61.8 | 60.9 | +0.89 | CL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.11 | 1.89 | -0.78 | TSLA | /macro-sensitivity <GO> |
| Forward P/E Multiple | 32.4x | 174.4x | -142.03 | CL | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $74.26B | $1.58T | -$1.51T | TSLA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CL REV | TSLA REV | CL GROSS % | TSLA GROSS % | CL FCF | TSLA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $20.38B | $94.83B | 60.1% | 18.0% | $3.28B | $6.22B |
| FY 2024 | $20.10B | $97.69B | 60.5% | 17.9% | $3.20B | $3.58B |
| FY 2023 | $19.46B | $96.77B | 44.0% | 18.3% | $2.87B | $4.36B |
| FY 2022 | — | $81.46B | — | 25.6% | — | $7.57B |
| FY 2021 | — | $53.82B | — | 25.3% | — | $5.01B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CL // BETA 1.11
TSLA // BETA 1.89